Cargando…
Mutational change of CTX‐M‐15 to CTX‐M‐127 resulting in mecillinam resistant Escherichia coli during pivmecillinam treatment of a patient
Pivmecillinam (amdinocillin pivoxil) is the recommended first‐choice antibiotic used to treat urinary tract infections (UTIs) in Denmark. The frequency of mutation to mecillinam (MEC) resistance is described as high in vitro; however, treatment of UTI has a good clinical response and prevalence of m...
Autores principales: | Nielsen, Karen Leth, Hansen, Katrine Hartung, Nielsen, Jesper Boye, Knudsen, Jenny Dahl, Schønning, Kristian, Frimodt‐Møller, Niels, Hertz, Frederik Boëtius, Jansåker, Filip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925186/ https://www.ncbi.nlm.nih.gov/pubmed/31573735 http://dx.doi.org/10.1002/mbo3.941 |
Ejemplares similares
-
Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not – a retrospective cohort study
por: Jansåker, Filip, et al.
Publicado: (2019) -
In vitro Relative Fitness, in vivo Intestinal Colonization and Genomic Differences of Escherichia coli of ST131 Carrying bla(CTX–M–15)
por: Hertz, Frederik Boëtius, et al.
Publicado: (2022) -
Escherichia coli belonging to ST131 rarely transfers bla(ctx-m-15) to fecal Escherichia coli
por: Thingholm, Karen Rønø, et al.
Publicado: (2019) -
Three versus five days of pivmecillinam for community-acquired uncomplicated lower urinary tract infection: A randomised, double-blind, placebo-controlled superiority trial()
por: Jansåker, Filip, et al.
Publicado: (2019) -
Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review
por: Jansåker, Filip, et al.
Publicado: (2018)